<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM759894 1"/></item><item><item key="GSM759895 1"/></item><item><item key="GSM759896 1"/></item><item><item key="GSM759897 1"/></item><item><item key="GSM759898 1"/></item><item><item key="GSM759899 1"/></item><item><item key="GSM759900 1"/></item><item><item key="GSM759901 1"/></item><item><item key="GSM759902 1"/></item><item><item key="GSM759903 1"/></item><item><item key="GSM759904 1"/></item><item><item key="GSM759905 1"/></item><item><item key="GSM759906 1"/></item><item><item key="GSM759907 1"/></item></item><item key="id">4172</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">We have used an agnostic approach to identify drug combinations by using combination high throughput screening (cHTS) technology and make...</item><item key="geo_gse_id">E-GEOD-30644</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">0</item><item key="sample_count">14</item><item key="tags"><item>cell</item><item>line</item><item>multiple myeloma</item><item>myeloma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">microarray-analysis-of-a-multiple-myeloma-cell-lin</item><item key="geo_id_plat">E-GEOD-30644_A-AFFY-44</item><item key="name">Microarray analysis of a multiple myeloma cell line, MM1S, treated with adenosine A2A and Beta-2 Adrenergic Receptor agonists in combination with dexamethasone</item><item key="created">Sep.16, 2014</item><item key="summary">We have used an agnostic approach to identify drug combinations by using combination high throughput screening (cHTS) technology and make the surprising discovery that adenosine A2A and beta-2 adrenergic receptor agonists are highly synergistic, selective and novel agents that enhance glucocorticoid activity in B-cell malignancies. We used the microarray study to understand the synergistic mechanism between dexamethasone and A2A receptor agonist or Beta-2 Adrenergic receptor agonist in a multiple myeloma cell line, MM1S. MM1S cells were treated with CGS-21680 or Salmeterol alone, or in combination with dexamethasone for six hours for RNA extraction and hybridization on Affymetrix microarrays.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-30644</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-30644/samples/</item></data></biogps>
